Corporate News     14-Jul-23
Gland Pharma's Dundigal Facility undergoes USFDA audit
Gland Pharma announced that the United States Food and Drug Administration (US FDA) has conducted Good Manufacturing Practice (GMP) Inspection at the Company's Dundigal Facility at Hyderabad between 03 July 2023 and 14 July 2023.

The inspection was concluded with ONE (1) 483 Observation. The corrective and preventive actions for this observation will be submitted to the US FDA within the stipulated period. The observation issued is neither a repeated observation nor related to data integrity.

Previous News
  Gland Pharma
 ( Results - Analysis 23-May-24   10:29 )
  Gland Pharma gets US FDA nod for Cetrorelix Acetate
 ( Hot Pursuit - 29-Apr-24   13:23 )
  Gland Pharma appoints Chief Operating Officer
 ( Corporate News - 29-Apr-24   14:51 )
  Gland Pharma consolidated net profit declines 15.30% in the June 2023 quarter
 ( Results - Announcements 07-Aug-23   18:19 )
  Gland Pharma slides after Q3 PAT drops 17% YoY to Rs 192 cr
 ( Hot Pursuit - 15-Feb-24   11:10 )
  Volumes spurt at Gland Pharma Ltd counter
 ( Hot Pursuit - 07-Nov-23   11:00 )
  Volumes soar at Gland Pharma Ltd counter
 ( Hot Pursuit - 19-Jun-24   11:00 )
  Gland Pharma to table results
 ( Corporate News - 09-May-24   14:47 )
  Indices trade higher; PSU bank shares advance
 ( Market Commentary - Mid-Session 29-Apr-24   14:34 )
  Gland Pharma Ltd Spurts 10.14%
 ( Hot Pursuit - 08-Aug-23   09:30 )
  Gland Pharma Ltd spurts 2.75%, up for third straight session
 ( Hot Pursuit - 23-Mar-23   13:05 )
Other Stories
  360 ONE WAM grants 21.47 lakh stock options
  05-Oct-24   11:32
  CARE reaffirms ratings on bank facilities of PNC Infratech's subsidiaries
  05-Oct-24   10:45
  CG Power & Industrial Solutions to acquire radio frequency components biz of Renesas
  05-Oct-24   10:30
  MMP Industries to convene board meeting
  05-Oct-24   10:23
  Mahindra & Mahindra Financial Serv. to discuss results
  05-Oct-24   10:23
  Ambey Laboratories to hold board meeting
  05-Oct-24   10:23
  Aurobindo Pharma's step down subsidiary to divest its entire stake in JV 'Novagen'
  05-Oct-24   10:21
  Aurobindo Pharma's step down subsidiary to divest its entire stake in a South African JV
  05-Oct-24   10:19
  Just Dial announces board meeting date
  05-Oct-24   10:11
  L&T Finance schedules board meeting
  05-Oct-24   10:11
Back Top